tiprankstipranks
Advertisement
Advertisement
Wuxi XDC’s Cash Offer for TOT BIOPHARM Falls Short of Control Threshold, Offer Extended
PremiumCompany AnnouncementsWuxi XDC’s Cash Offer for TOT BIOPHARM Falls Short of Control Threshold, Offer Extended
2M ago
BioDlink Sets March Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
BioDlink Sets March Board Meeting to Approve 2025 Annual Results
3M ago
BioDlink Clarifies Outstanding Share Options Amid Takeover Process
Premium
Company Announcements
BioDlink Clarifies Outstanding Share Options Amid Takeover Process
3M ago
BioDlink Appoints Independent Adviser for WuXi XDC’s Conditional Takeover Offer
PremiumCompany AnnouncementsBioDlink Appoints Independent Adviser for WuXi XDC’s Conditional Takeover Offer
4M ago
TOT BIOPHARM Receives Voluntary Cash Offer at 99% Premium
Premium
Company Announcements
TOT BIOPHARM Receives Voluntary Cash Offer at 99% Premium
4M ago
BioDlink Clarifies Pre-IPO Share Option Scheme and Expiry in Supplemental Annual Report
Premium
Company Announcements
BioDlink Clarifies Pre-IPO Share Option Scheme and Expiry in Supplemental Annual Report
5M ago
BioDlink International Announces Leadership Restructuring
PremiumCompany AnnouncementsBioDlink International Announces Leadership Restructuring
7M ago
BioDlink International Announces Board and Committee Restructuring
Premium
Company Announcements
BioDlink International Announces Board and Committee Restructuring
7M ago
BioDlink Reports Revenue Decline Amidst Global Expansion Efforts
Premium
Company Announcements
BioDlink Reports Revenue Decline Amidst Global Expansion Efforts
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100